ArticleMolecular therapy. Methods & clinical development2022

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse.

Nicolas Wein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.